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Abstract
Background: Ticks are common ectoparasites that infest dogs globally. Acaricides with rapid and sustained speed
of kill are critical to control infestations and to reduce the risk of disease transmission. This study evaluated the
speed of kill for 5 weeks after a single dose of orally administered Simparica™(sarolaner) against induced infestations
with Dermacentor reticulatus on dogs, compared to Advantix®Spot-on solution for dogs (imidacloprid + permethrin).
Methods: Twenty four dogs were randomly allocated to treatment with either a placebo tablet, a sarolaner tablet
(at 2 to 4 mg/kg) or with Advantix® as per label instructions. Dogs were treated on Day 0 and tick counts were
performed in situ at 8 and 12 hours and with removal of the ticks at 24 hours after treatment and subsequent
re-infestations on Days 7, 14, 21, 28 and 35. Acaricidal efficacy was determined at each time point relative to live
tick counts from the placebo-treated dogs.
Results: Based on arithmetic (geometric) mean tick counts, the efficacy of sarolaner was ≥75.6 % (89.6 %) within
8 hours of treatment and tick counts were significantly lower than placebo and imidacloprid + permethrin-treated
dogs (P < 0.0001), while imidacloprid + permethrin had no significant reduction (P≥ 0.3990) at 8 or 12 hours after
treatment. Sarolaner killed all ticks on the dogs within 24 hours after treatment, while imidacloprid + permethrin
efficacy was only 48.1 %. After weekly re-infestations sarolaner significantly reduced the tick counts versus placebo
within 8 hours on Days 7, 14 and 35 (P≤ 0.0239), and at 12 hours and 24 hours (P ≤ 0.0079) until Day 35.Sarolaner
efficacy was ≥95.8 % within 24 hours for 35 days. Significantly more live ticks (P ≤ 0.0451) were recovered from
imidacloprid + permethrin-treated dogs than from sarolaner-treated dogs at 24 hours after infestation on all days.
There were no sarolaner-related adverse reactions during the study.
Conclusions: This study demonstrated that Simparica™ had a faster and more consistent speed of kill against D.
reticulatus compared to Advantix®. The rapid and consistent efficacy within 24 hours for 5 weeks after a single oral
dose of Simparica™ provides effective and reliable control of D. reticulatus and reduces the risk of transmission of
tick-borne diseases.
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Background
Dermacentor reticulatus, also known as the ornate dog
tick or meadow tick, infests dogs throughout Europe.
Recently there have been several reports about the po-
tential expansion and increased prevalence of this tick in
Europe [1–7]. D. reticulatus is also a known vector for
Babesia canis, an intracellular protozoan parasite that is
a threat to dogs as a cause of anemia, thrombocytopenia,
and various clinical signs, ranging from mild, nonspecific
illness to peracute collapse and death [8, 9]. As aware-
ness of tick-borne diseases has increased, tick control
and prevention have taken on a new importance. Until
recently, topically administered parasiticides with con-
tact activity have been the only available option for tick
control on dogs. These products are generally perceived
to have the potential to kill or repel ticks before they
bite, reducing the risk of disease transmission.
Simparica™(sarolaner) is a novel parasiticide from the
isoxazoline class of molecules, and provides a new ef-
fective alternative for the control of ticks, including D.
reticulatus for at least 5 weeks after a single oral dose
[10]. As systemically active compounds require the tick
to bite to receive a lethal dose of the parasiticide, it is
important that these compounds act rapidly and consist-
ently. A single dose of sarolaner provides greater than
90 % efficacy within 24 hours for at least 4 weeks against
common ticks worldwide and within 12 hours against
Ixodes ricinus, the most widely distributed tick species in
Europe [11]. While tick efficacy claims are based on
evaluation at 48 hours after treatment or re-infestation
[12], the speed of acaricidal activity is critical in prevent-
ing feeding and thus reducing the risk of disease trans-
mission which occurs after the infected tick is attached
and feeding for at least 24 to 48 hours [13, 14]. The
present study was conducted to evaluate and compare
the speed of kill of a single oral dose of sarolaner with
that of imidacloprid + permethrin (Advantix® Spot-on so-
lution for dogs), against an existing infestation and
against weekly re-infestations with D. reticulatus for a
period of 5 weeks after treatment.
Methods
Ethical approval
Study procedures were in accordance with the World
Association for the Advancement of Veterinary Parasit-
ology (WAAVP) guidelines for evaluating the efficacy of
parasiticides for the treatment, prevention and control
of flea and tick infestation on dogs and cats [12]. The
protocol was reviewed and approved by the Zoetis Eth-
ical Review Board and the local Animal Welfare Com-
mittee. Masking of the study was assured through the
separation of study functions. All personnel conducting
observations or animal care or performing infestations
and counts were masked to treatment allocation.
Animals
Twenty-four (8 male and 16 female) purpose-bred Bea-
gle and mixed breed dogs from 9 months to 6 years of
age and weighing from 10.8 to 24.8 kg were used in the
study. Each dog had undergone an adequate wash-out
period to ensure that no residual ectoparasiticide efficacy
remained from any previous administration. Dogs were
individually housed and were acclimatized to these con-
ditions for at least 8 days prior to treatment. Dogs were
fed an appropriate maintenance ration of a commercial
canine diet for the duration of the study. Water was
available ad libitum. All dogs were given a physical
examination to ensure that they were in good health at
enrollment and were suitable for inclusion in the study.
General health observations were performed twice daily
throughout the study.
Design
The study followed a randomized complete block design.
Dogs were ranked according to decreasing tick counts
into blocks of three animals, and within each block a
dog was randomly allocated to one of three treatment
groups. There were eight dogs per treatment group. The
average hair length in each group was similar.
Treatment
On Day 0, dogs received either a placebo tablet, an ap-
propriate Simparica™ chewable tablet (sarolaner at 2 to
4 mg/kg) or a topical application of Advantix® Spot-on
solution for dogs (imidacloprid + permethrin at 10 to
25 mg/kg imidacloprid and 50 to125 mg/kg permethrin).
The Day -2 bodyweights were used to calculate the ap-
propriate dosage to be administered. The tablet(s) were
administered by hand pilling to ensure accurate and
complete dosing. Each dog was observed for several mi-
nutes after dosing for evidence that the dose was swal-
lowed, and for potential adverse events associated with
treatment administration. Dogs were observed approxi-
mately two hours after dosing for evidence of emesis.
The imidacloprid + permethrin treatment was applied
topically following the label directions.
Tick infestation and assessment
The D. reticulatus strain used for infestation was estab-
lished in 2007 in Ireland. The colony was genetically
enriched by the addition of wild-caught ticks from the
Netherlands in 2009 and 2012. Tick infestations were
performed on Days -7,-2, 7, 14, 21, 28 and 35. Prior to
each infestation, the dog was sedated to enhance tick at-
tachment, and 50 (±5) viable unfed adult D. reticulatus
(1:1 male:female) was directly applied to each animal.
Each dog was examined to remove and count live ticks
at 48 hours after the infestation on Day -7, to confirm
host suitability and counts were used for allocation to
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treatments. On Days 0, 7, 14, 21, 28 and 35, the dogs were
examined 8 and 12 (±0.5) hours after treatment or each
subsequent weekly re-infestation, and live ticks were
counted in situ; the dogs were systematically examined so
that the entire body surface was carefully examined once.
At 24 (±0.5) hours after treatment and each subsequent
weekly re-infestation, the dogs were examined and then
thoroughly combed to count and remove ticks. Each dog
was examined for at least 10 minutes. If ticks were en-
countered in the last minute, combing was continued in
one minute increments until no ticks were encountered.
Statistical analysis
The individual dog was the experimental unit. Data for
post-treatment live (free plus attached) tick counts were
summarized with arithmetic (AM) and geometric (GM)
means by treatment group and time-point. Tick counts
were transformed by the loge (count + 1) transformation
prior to analysis in order to stabilize the variance and
normalize the data. Using the PROC MIXED procedure
(SAS 9.2, Cary NC), transformed counts were analyzed
using a mixed linear model for repeated measures. The
fixed effects were treatment, time-point and the treat-
ment by time-point interaction. Random effects included
room, block within room, block by treatment interaction
within room, and error. Testing was two-sided at the
significance level α = 0.05.
The assessment of acaricidal efficacy was based on the
percent reduction in the arithmetic and geometric mean
live tick counts relative to placebo, as suggested by the
most recent WAAVP guidelines [12], and was calculated
using Abbott’s formula:
% reduction ¼ 100 mean count placeboð Þ– mean count treatedð Þ
mean count placeboð Þ
Results
The results of the tick counts at each time-point are
provided in Tables 1, 2 and 3, and in Fig. 1. Placebo-
treated dogs maintained adequate tick infestations
throughout the study. AM (GM) live tick counts for the
placebo-treated dogs at the 8-hour tick count ranged
from 23.5 (21.7) to 35.8 (34.5); at the 12-hour count
from 20.5 (18.3) to 33.6 (32.3); and at the 24-hour count
from 25.0 (23.0) to 30.1 (28.7).
Eight hours after treatment the reduction in AM (GM)
tick counts was 75.6 % (89.6 %) for sarolaner and 5.6 %
(14.6 %) for imidacloprid + permethrin. Geometric mean
live tick counts were significantly lower (P < 0.0001) than
placebo for sarolaner but not forimidacloprid + permethrin
(P = 0.6216).Eight hours after the subsequent weekly re-
infestations the reduction in AM (GM) tick counts for
sarolaner ranged from 30.0 % (29.6 %) to 65.0 % (66.4 %).
GM live tick counts for sarolaner were significantly lower
(P≤ 0.0239) than placebo, except on Days 21 and 28.
Table 1 The Range, Arithmetic (AM) and Geometric (GM) Mean live Dermacentor reticulatus counts, and efficacy relative to placebo
at 8 hours after treatment and re-infestations for dogs treated with either a single oral dose of sarolaner or a single topical
application of imidacloprid+permethrin on Day 0
Treatment Day of treatment or re-infestation
0 7 14 21 28 35
Placebo Range 23 to 43 12 to 34 26 to 43 13 to 40 21 to 39 20 to 43
AM 33.8 23.5 35.8 28.4 32.4 35.4
GMc 32.4a 21.7a 34.5a 26.4a 31.2a 33.7a
Sarolaner Range 0 to 31 6 to 21 8 to 22 12 to 27 13 to 30 12 to 33
AM 8.3 13.1 12.5 19.9 22.1 21.1
AM Efficacy (%) 75.6 44.1 65.0 30.0 31.7 40.3
GMc 3.4b 12.1b 11.6b 18.6a 20.6a 19.8b
GM Efficacy (%) 89.6 44.1 66.4 29.6 33.9 41.2
P-value vs. placebo <0.0001 0.0157 <0.0001 0.1349 0.0766 0.0239
Imidacloprid+permethrin Range 6 to 45 0 to 33 2 to 18 0 to 18 5 to 20 7 to 42
AM 31.9 9.9 8.9 6.9 14.3 19.5
AM Efficacy (%) 5.6 58.0 75.2 75.8 56.0 44.9
GMc 27.6a 4.2c 7.2b 4.7b 12.8b 16.8b
GM Efficacy (%) 14.6 80.6 79.0 82.0 58.9 50.2
P-value vs. placebo 0.6216 <0.0001 <0.0001 <0.0001 0.0074 0.0331
P-value vs. sarolaner <0.0001 0.0077 0.2152 0.0005 0.1917 0.6461
c Geometric means within columns with the same superscript are not significantly different (P >0.05)
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Table 2 The Range, Arithmetic (AM) and Geometric (GM) Mean live Dermacentor reticulatus counts, and efficacy relative to placebo
at 12 hours after treatment and re-infestations for dogs treated with either a single oral dose of sarolaner or a single topical
application of imidacloprid+permethrin on Day 0
Treatment Day of treatment or re-infestation
0 7 14 21 28 35
Placebo Range 23 to 41 6 to 35 23 to 41 12 to 37 19 to 34 12 to 43
AM 33.6 20.5 31.3 27.0 28.5 33.3
GMc 32.3a 18.3a 30.1a 25.2a 27.3a 30.6a
Sarolaner Range 0 to 7 3 to 15 6 to 13 1 to 24 9 to 24 10 to 28
AM 1.4 8.6 8.6 11.0 15.6 16.9
AM Efficacy (%) 95.9 57.9 72.4 59.3 45.2 49.2
GMc 0.6b 7.7b 8.2b 8.4b 14.5b 15.7b
GM Efficacy (%) 98.0 58.0 72.7 66.8 47.0 48.7
P-value vs. placebo <0.0001 0.0005 <0.0001 <0.0001 0.0079 0.0051
Imidacloprid+permethrin Range 6 to 41 0 to 29 0 to 16 0 to 10 3 to 16 7 to 36
AM 28.1 7.5 6.3 4.4 8.4 17.5
AM Efficacy (%) 16.4 63.4 80.0 83.8 70.6 47.4
GMc 24.6a 3.5b 4.2b 3.3c 7.2b 14.7b
GM Efficacy (%) 23.7 80.8 85.9 87.0 73.8 51.9
P-value vs. placebo 0.3990 <0.0001 <0.0001 <0.0001 0.0001 0.0259
P-value vs. sarolaner <0.0001 0.0578 0.1025 0.0231 0.0630 0.8596
c Geometric means within columns with the same superscript are not significantly different (P >0.05)
Table 3 The Range, Arithmetic (AM) and Geometric (GM) Mean live Dermacentor reticulatus counts, and efficacy relative to placebo
at 24 hours after treatment and re-infestations for dogs treated with either a single oral dose of sarolaner or a single topical
application of imidacloprid+permethrin on Day 0
Treatment Day of treatment or re-infestation
0 7 14 21 28 35
Placebo Range 21 to 40 10 to 37 15 to 37 15 to 38 18 to 33 7 to 41
AM 30.1 25.0 28.4 28.1 28.0 27.0
GMd 28.7a 23.0a 26.6a 26.7a 26.9a 24.0a
Sarolaner Range 0 to 0 0 to 1 0 to 0 0 to 1 0 to 3 0 to 5
AM 0.0 0.3 0.0 0.1 0.9 1.1
AM Efficacy (%) 100.0 99.0 100.0 99.6 96.9 95.8
GMd 0.0c 0.2c 0.0c 0.1c 0.5c 0.6c
GM Efficacy (%) 100 99.3 100 99.8 98.0 97.6
P-value vs. placebo <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Imidacloprid+permethrin Range 7 to 33 0 to 8 0 to 18 0 to 11 0 to 17 1 to 32
AM 15.6 2.3 4.6 3.3 6.3 14.5
AM Efficacy (%) 48.1 91.0 83.7 88.4 77.7 46.3
GMd 13.9b 1.3b 2.3b 1.9b 4.1b 10.4b
GM Efficacy (%) 51.5 94.3 91.3 93.0 84.9 56.8
P-value vs. placebo 0.0282 <0.0001 <0.0001 <0.0001 <0.0001 0.0124
P-value vs. sarolaner <0.0001 0.0451 0.0005 0.0045 0.0006 <0.0001
d Geometric means within columns with the same superscript are not significantly different (P >0.05)
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Forimidacloprid + permethrin, the reduction in AM (GM)
mean tick counts ranged from 44.9 % (50.2 %) to 75.8 %
(82.0 %), and were significantly lower (P≤ 0.0331) than pla-
cebo on all days. GM live tick counts for the two products
were significantly different from each other on Days 0, 7
and 21 (P≤ 0.0077).
Twelve hours after treatment the reduction in AM
(GM) tick counts was 95.9 % (98.0 %) for sarolaner
and 16.4 % (23.7 %) for imidacloprid + permethrin.
GM live tick counts for sarolaner were significantly
lower (P < 0.0001) than for placebo, but were not for
imidacloprid + permethrin (P = 0.3990) versus pla-
cebo. On the sarolaner-treated dogs only up to 7 live ticks
were found, while on the imidacloprid + permethrin
treated dogs up to 41 live ticks were recovered. Twelve
hours after weekly re-infestation the reduction in AM
(GM) tick counts for sarolaner ranged from 45.2 %
(47.0 %) to 72.4 % (72.7 %) (P≤ 0.0079 on all days vs pla-
cebo). Forimidacloprid + permethrin, the reduction in AM
(GM) mean tick counts ranged from 47.4 % (51.9 %) to
83.8 % (87.0 %) (P≤ 0.0259 on all days vs. placebo). GM
live tick counts for sarolaner were significantly lower than
those for imidacloprid + permethrinon Days 0 and 21
(P≤ 0.0231).
Twenty four hours after treatment no live ticks were
found on any sarolaner-treated dog (100 % efficacy),
while up to 33 live ticks were recovered from imidaclo-
prid + permethrin treated dogs, representing 48.1 %
(51.5 %) efficacy. GM live tick counts were significantly
lower than placebo for sarolaner (P < 0.0001) and
imidacloprid + permethrin (P ≤ 0.0282). Twenty four
hours after weekly re-infestation, the reduction in AM
(GM) tick counts for sarolaner was above 95.8 %
(97.6 %) until Day 35 (P < 0.0001 vs. placebo on all
days). Forimidacloprid + permethrin, the percentage
reduction in AM (GM) tick counts ranged from 91.0 %
(94.3 %), to 46.3 % (56.8 %) (P ≤ 0.0124 vs. placebo on
all days). Geometric mean live tick counts for sarola-
ner were significantly lower than those for imidaclo-
prid + permethrin on all days (P ≤ 0.0451).There were
no sarolaner-related adverse reactions during the
study. One imidacloprid + permethrin-treated dog de-
veloped erythema on Day 0 at the site of treatment
application.
Discussion
A rapid speed of kill prevents the direct adverse effects of
tick attachment and feeding, and reduces the risk for
transmission of tick-borne pathogens. In this study, a sin-
gle dose of sarolaner significantly reduced D. reticulatus
tick counts within 8 hours after treatment, and within
12 hours after re-infestation for 35 days. Efficacy above
90 % was achieved within 24 hours and maintained for
35 days after treatment. The persistent and rapid speed
of kill against D. reticulatus for 5 weeks is consistent
with the rapid efficacy of sarolaner within 24 hours
against Ixodes ricinus, Ixodes scapularis and
Amblyomma maculatum for at least 4 weeks [11].
The efficacy of imidacloprid + permethrin within
48 hours of treatment against D. reticulatus in dogs has
previously been described, with adequate efficacy in the
first two weeks after treatment and a decline in efficacy
from the third week onwards [15, 16]. Additionally, the
efficacy of imidacloprid + permethrin at 24 hours post-
treatment or re-infestation was below 90 % efficacy
throughout the entire month in another study [17].
Similarly, in the present study, based on arithmetic mean
the efficacy of imidacloprid + permethrin at 24 hours
was below 90 % at all time-points except on Day 7. As a
result, significantly (P ≤ 0.0451) more ticks were found
Fig. 1 Percent efficacy based on arithmetic mean Dermacentor reticulatus counts relative to placebo at 24 hours after treatment and weekly
post-treatment re-infestation for dogs treated with either a single oral dose of sarolaner or a single topical application of imidacloprid plus
permethrin on Day 0
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at 24 hours on imidacloprid + permethrin-treated dogs
compared to sarolaner-treated dogs throughout the
study. The fact that imidacloprid + permethrin had no
significant effect within 12 hours after treatment and
<50 % efficacy at 24 hours, as well as the lower efficacy
throughout the month at all time-points except at
24 hours on Day 7, are evidence of a slow speed of kill
for imidacloprid + permethrin.
The ornate dog tick is a well-known vector of B. canis.
Transmission of babesiosis is considered to occur within 24
to 72 hours of tick attachment [13, 14]. As dogs can be ex-
posed to infected ticks throughout the treatment interval,
both persistent efficacy and rapid speed of kill are required
to decrease the risk of babesiosis. Under field conditions
imidacloprid + permethrin has demonstrated a 94.4 % re-
duction in the incidence of infection with Babesia spp in
dogs [18]. Therefore the faster and more persistent killing
effect of sarolaner against D. reticulatus for at least 5 weeks
in the present study highlights the potential of sarolaner
to reduce the transmission of babesiosis to dogs.
Conclusions
This study confirmed the rapid and consistent acaricidal
efficacy of sarolaner against D. reticulatus after a single
oral administration and demonstrated that ticks were
killed rapidly with >90 % efficacy within 24 hours for at
least 5 weeks. Efficacy of Simparica™ was higher at
24 hours compared to Advantix® throughout the study.
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